Mekonos, Inc.
Biotechnology company · San Francisco, California, United States
Mekonos, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2021.
Mekonos at a glance
What does Mekonos do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $25 million sold (2021).
Frequently asked questions about Mekonos
Where is Mekonos headquartered?
Mekonos, Inc. is headquartered in San Francisco, California, United States.
What does Mekonos do?
Mekonos, Inc. is a biotechnology company.
When was Mekonos founded?
The earliest incorporation on record for Mekonos, Inc. is in 2017, according to public company registers.
Similar companies
- Ossium Health, Inc.San Francisco, California, United States
- Vir Biotechnology, Inc.San Francisco, California, United States
- Titan Pharmaceuticals IncSan Francisco, California, United States
- Senti Biosciences, Inc.San Francisco, California, United States
- Amygdala Neurosciences IncSan Francisco, California, United States
- Excision BioTherapeutics IncSan Francisco, California, United States
- ProLynx, Inc.San Francisco, California, United States
- Second Genome, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences